Nattawat Klomjit MD
Acute Renal Failure, Chronic Renal Failure & Dialysis, Glomerular Disease, Hypertension
Assistant Professor of Medicine, Division of Nephrology and Hypertension, University of Minnesota
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Klomjit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am both board certified in Internal Medicine and Nephrology. I have received my nephrology training at the Mayo Clinic, Rochester, Minnesota. I am an assistant professor of medicine in the division of Nephrology and Hypertension at the University of Minnesota. I am passionate in glomerulonephritis, onco-nephrology and thrombotic microangiopathy.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Nephrology, 2018 - 2021
University of HawaiiResidency, Internal Medicine, 2015 - 2018
Siriraj Medical School/Mahidol UniversityClass of 2011
Certifications & Licensure
MN State Medical License 2018 - 2025
OH State Medical License 2016 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Excellence Teaching Award Department of Medicine, University of Minnesota, 2023
Publications & Presentations
PubMed
- 1 citationsDiagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrology.Sandra M Herrmann, Ala Abudayyeh, Shruti Gupta, Prakash Gudsoorkar, Nattawat Klomjit
Kidney International. 2025-01-01 - Kidneys and commonly used medications: how to reduce a risk of acute kidney injury in everyday practice?Sean Pickthorn, Peter Thorne, Nattawat Klomjit
Polish Archives of Internal Medicine. 2024-09-27 - Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies-Perspectives from the American Society of Onco-Nephrology (ASON).Abhijat Kitchlu, Verônica T Costa E Silva, Shuchi Anand, Jaya Kala, Ala Abudayyeh
Clinical Journal of the American Society of Nephrology. 2024-08-01
Other Languages
- Thai
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
